Compound Summary
Compound Name: | n-bromoacetamide |
Compound CID: | 4353 |
Synonyms: | n-bromoacetamide 79-15-2 Acetamide, N-bromo- UNII-0AQ6MWH7ZB 0AQ6MWH7ZB More... |
Iupac Name: | N-bromoacetamide |
InChI: | InChI=1S/C2H4BrNO/c1-2(5)4-3/h1H3,(H,4,5) |
InChIKey: | VBTQNRFWXBXZQR-UHFFFAOYSA-N |
Canonical Smiles: | CC(=O)NBr |
Isomeric Smiles: | CC(=O)NBr |
Molecular Weight: | 137.96 |
Molecular Formula: | C2H4BrNO |
Molecular Weight: | 137.96 |
Molecular Formula: | C2H4BrNO |
Hydrogen Bond Donor Count: | 1 |
Hydrogen Bond Acceptor Count: | 1 |
Rotatable Bond Count: | 0 |
Heavy Atom Count: | 5 |
Complexity: | 44.9 |
n-bromoacetamide | n-bromoacetamide |
---|---|
n-bromoacetamide |
79-15-2 |
Acetamide, N-bromo- |
UNII-0AQ6MWH7ZB |
0AQ6MWH7ZB |
CCRIS 4590 |
EINECS 201-181-0 |
N-bromo-acetamide |
MFCD00037097 |
ACMC-209pgg |
N-Bromoacetamide, powder |
Lopac-B-2377 |
SCHEMBL1658 |
Lopac0_000191 |
CHEMBL1256514 |
DTXSID5024633 |
HMS3260H03 |
ZINC3874381 |
Tox21_500191 |
6847AF |
AKOS015836195 |
CCG-204286 |
LP00191 |
SDCCGSBI-0050179.P002 |
NCGC00015145-01 |
NCGC00015145-02 |
NCGC00015145-03 |
NCGC00015145-04 |
NCGC00015145-05 |
NCGC00093667-01 |
NCGC00093667-02 |
NCGC00260876-01 |
AS-39373 |
BP-10839 |
DB-003101 |
B0530 |
EU-0100191 |
FT-0653546 |
B 2377 |
A839598 |
SR-01000075710 |
SR-01000075710-1 |
Q27236544 |
Species | Dose | Unit | Control(Avg days) | Treatment(Avg days) | Avg/Med Lifespan Change(%) | Control(Max days) | Treatment(Max days) | Max Lifespan Change(%) | Significant | Strain | Gender | PubMed | Avg/Med Lifespan Change tab |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Caenorhabditis elegans | 33.000000000000000 | umol/L | -3.000000000000000 | NS | N2 | 24134630 | Inactive |
Species | Avg/Med Lifespan Change(%) | Max Lifespan Change(%) | Count Reference | Count Data point |
---|---|---|---|---|
Caenorhabditis elegans | -3.000000000000000 | 1 | 1 |